Cerity Partners LLC Increases Stake in Repligen Co. (NASDAQ:RGEN)

Cerity Partners LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 333.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,929 shares of the biotechnology company’s stock after buying an additional 6,100 shares during the period. Cerity Partners LLC’s holdings […]

Related Keywords

United States ,America ,Karena Dawes ,Stifel Nicolaus ,Craig Hallum ,Asia Pacific ,Whittier Trust Co ,Wells Fargo Company ,Fortis Capital Advisors ,Cerity Partners ,Repligen Co ,Covestor Ltd ,Clearstead Advisors ,Securities Exchange Commission ,Repligen Corporation ,Nasdaq ,Free Report ,Capital Advisors ,Get Free Report ,Director Karen ,Exchange Commission ,North America ,Repligen Daily ,Repligen ,Nasdaq Rgen ,Rgen ,Medical ,75991610 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,